Chang Xiu-Bao, Stewart A Keith
Mayo Clinic College of Medicine, Mayo Clinic Arizona Scottsdale, AZ 85259 USA.
Int J Biochem Mol Biol. 2011;2(3):287-94. Epub 2011 Sep 10.
It has been found that nonsense mutation R419X of cereblon (CRBN) is associated with autosomal recessive non-syndromic mental retardation. Further experiments showed that CRBN binds to the cytosolic C-terminus of large-conductance Ca(++) activated potassium channel (BK(Ca)) α-subunit and the cytosolic C-terminus of a voltage-gated chloride channel-2 (ClC-2), suggesting that CRBN may play a role in memory and learning via regulating the assembly and surface expression of BK(Ca) and ClC-2 channels. In addition, it has also been found that CRBN directly interacts with the α1 subunit of AMP-activated protein kinase (AMPK) and prevents formation of a functional holoenzyme with regulatory subunits β and γ. Since AMPK is a master sensor of energy balance that inhibits ATP-consuming anabolic pathways and increases ATP-producing catabolic pathways, binding of CRBN with α1 subunit of AMPK may play a role in these pathways by regulating the function of AMPK. Furthermore, CRBN interacts with damaged DNA binding protein 1 and forms an E3 ubiquitin ligase complex with Cullin 4 where it functions as a substrate receptor in which the proteins recognized by CRBN might be ubiquitinated and degraded by proteasomes. Proteasome-mediated degradation of unneeded or damaged proteins plays a very important role in maintaining regular function of a cell, such as cell survival, dividing, proliferation and growth. Intriguingly, a new role for CRBN has been identified, i.e, the binding of immunomodulatory drugs (IMiDs), e.g. thalidomide, to CRBN has now been associated with teratogenicity and also the cytotoxicity of IMiDs, including lenalidomide, which are widely used to treat multiple myeloma patients. CRBN likely plays an important role in binding, ubiquitination and degradation of factors involved in maintaining function of myeloma cells. These new findings regarding the role of CRBN in IMiD action will stimulate intense investigation of CRBN's downstream factors involved in maintaining regular function of a cell.
已发现大脑空洞蛋白(CRBN)的无义突变R419X与常染色体隐性非综合征性智力发育迟缓相关。进一步实验表明,CRBN与大电导钙激活钾通道(BK(Ca))α亚基的胞质C末端以及电压门控氯通道-2(ClC-2)的胞质C末端结合,这表明CRBN可能通过调节BK(Ca)和ClC-2通道的组装及表面表达在记忆和学习中发挥作用。此外,还发现CRBN直接与AMP激活的蛋白激酶(AMPK)的α1亚基相互作用,并阻止其与调节亚基β和γ形成功能性全酶。由于AMPK是能量平衡的主要传感器,可抑制消耗ATP的合成代谢途径并增加产生ATP的分解代谢途径,CRBN与AMPKα1亚基的结合可能通过调节AMPK的功能在这些途径中发挥作用。此外,CRBN与损伤DNA结合蛋白1相互作用,并与Cullin 4形成E3泛素连接酶复合物,在其中作为底物受体发挥作用,被CRBN识别的蛋白质可能会被泛素化并由蛋白酶体降解。蛋白酶体介导的对不需要或受损蛋白质的降解在维持细胞的正常功能(如细胞存活、分裂、增殖和生长)中起着非常重要的作用。有趣的是,已确定CRBN的一个新作用,即免疫调节药物(IMiDs),如沙利度胺,与CRBN的结合现在已与致畸性以及IMiDs的细胞毒性相关,包括广泛用于治疗多发性骨髓瘤患者的来那度胺。CRBN可能在与维持骨髓瘤细胞功能有关的因子的结合、泛素化和降解中起重要作用。这些关于CRBN在IMiD作用中角色的新发现将激发对参与维持细胞正常功能的CRBN下游因子的深入研究。